A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive p
![PDF) Data management and data analysis techniques in pharmacoepidemiological studies using a pre-planned multi-database approach: A systematic literature review PDF) Data management and data analysis techniques in pharmacoepidemiological studies using a pre-planned multi-database approach: A systematic literature review](https://i1.rgstatic.net/publication/280111554_Data_management_and_data_analysis_techniques_in_pharmacoepidemiological_studies_using_a_pre-planned_multi-database_approach_A_systematic_literature_review/links/55aa388508ae481aa7fb1176/largepreview.png)
PDF) Data management and data analysis techniques in pharmacoepidemiological studies using a pre-planned multi-database approach: A systematic literature review
A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive p
Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1 updates to tumour pathology
![PDF) Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1 -like status, tumor-infiltrating immune cells and survival PDF) Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1 -like status, tumor-infiltrating immune cells and survival](https://i1.rgstatic.net/publication/327588005_Assessment_of_PD-L1_expression_across_breast_cancer_molecular_subtypes_in_relation_to_mutation_rate_BRCA1_-like_status_tumor-infiltrating_immune_cells_and_survival/links/5ebab78092851c11a8612dde/largepreview.png)
PDF) Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1 -like status, tumor-infiltrating immune cells and survival
A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive p
![PDF) Recurrent HOXB13 mutations in the Dutch population do not associate with increased breast cancer risk PDF) Recurrent HOXB13 mutations in the Dutch population do not associate with increased breast cancer risk](https://i1.rgstatic.net/publication/305413219_Recurrent_HOXB13_mutations_in_the_Dutch_population_do_not_associate_with_increased_breast_cancer_risk/links/579eedfa08ae80bf6ea6e404/largepreview.png)
PDF) Recurrent HOXB13 mutations in the Dutch population do not associate with increased breast cancer risk
![PDF) Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C , RAD51D , BARD1 updates to tumour pathology and cancer incidence PDF) Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C , RAD51D , BARD1 updates to tumour pathology and cancer incidence](https://i1.rgstatic.net/publication/364056892_Enhancing_the_BOADICEA_cancer_risk_prediction_model_to_incorporate_new_data_on_RAD51C_RAD51D_BARD1_updates_to_tumour_pathology_and_cancer_incidence/links/63615dd1431b1f53005ff12b/largepreview.png)
PDF) Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C , RAD51D , BARD1 updates to tumour pathology and cancer incidence
![PDF) Clinicopathological Risk Factors for an Invasive Breast Cancer Recurrence after Ductal Carcinoma In Situ-A Nested Case-Control Study PDF) Clinicopathological Risk Factors for an Invasive Breast Cancer Recurrence after Ductal Carcinoma In Situ-A Nested Case-Control Study](https://i1.rgstatic.net/publication/324708614_Clinicopathological_Risk_Factors_for_an_Invasive_Breast_Cancer_Recurrence_after_Ductal_Carcinoma_In_Situ-A_Nested_Case-Control_Study/links/5c08dd7f92851c39ebd62d8c/largepreview.png)